7 Amendments of Cristian TERHEŞ related to 2021/2167(INI)
Amendment 17 #
Motion for a resolution
Recital I
Recital I
I. whereas publicity and transparency are the main principles underlying the EU legislative process, as confirmed by the case law of the CJEU, which provided clear legal guidance on the way to ensure their full and consistent respect; whereas the CJEU stated that the lack of transparency and information weakens citizens’ trust in the legitimacy of the EU legislative process as a whole; whereas, contrary to these principles, the Commission was not transparent in the negotiation, purchase and distribution of COVID-19 vaccines;
Amendment 18 #
Motion for a resolution
Recital I a (new)
Recital I a (new)
I a. whereas the right to know of the EU citizens and the obligation to full transparency of the EU institutions, especially when it comes to COVID-19 vaccine contracts between the EU institution and the pharmaceutical companies, prevail over any alleged right of the pharmaceutical companies or the EU institution to hide or not to fully disclose any or some information related to these contracts or COVID-19 vaccines;
Amendment 33 #
Motion for a resolution
Recital Q a (new)
Recital Q a (new)
Q a. whereas many petitions received by the PETI Committee are related to the lack of transparency of the European Commission and request that full details of the COVID-19 vaccine contracts signed between the Commission, the Member States and the pharmaceutical industry, as well as patient-level clinical trials data will be published;
Amendment 39 #
Motion for a resolution
Paragraph 2 a (new)
Paragraph 2 a (new)
2 a. Congratulates the Ombudsman for monitoring how the EU’s frontline institutions are carrying out their work during the pandemic and for underlining their obligation for transparency; welcomes the question addressed by the Ombudsman to the Commission about the transparency of the scientific advice it receives, its meetings with interest representatives, and its decisions related to emergency public procurement;
Amendment 48 #
Motion for a resolution
Paragraph 6 a (new)
Paragraph 6 a (new)
6 a. Calls on the Commission to publish non-redacted versions of the Advance Purchase Agreements and the Purchase Agreement, as well as to make the disclosure of all details of future COVID-19 vaccine contracts a precondition for any future negotiations with the pharmaceutical companies;
Amendment 51 #
Motion for a resolution
Paragraph 7 a (new)
Paragraph 7 a (new)
7 a. Encourages the Ombudsman to continue its inquiries and to ask the Commission to publish non-redacted versions of the Advance Purchase Agreements and the Purchase Agreement and to disclose: the advance payments by the Commission, the cost sharing between public and private investments in the vaccines, the prices per dose, the liability and compensation regimes for any harm that might be caused by the vaccines, the sanctions in case of breach of contract;
Amendment 81 #
Motion for a resolution
Paragraph 16 a (new)
Paragraph 16 a (new)
16 a. Applauds the Ombudsman for opening an own-initiative inquiry into the extraordinary decision-making procedures put in place by the Council of the EU in the context of the COVID-19 crisis;